OBIO® partners with Ontario Centre of Innovation to advance innovation and accelerate commercialization

We are delighted to work alongside Ontario Centre of Innovation and our partners at Life Sciences Central, MaRS and TIAP, to advance high-potential start-ups, accelerate adoption of innovation, and position Ontario as a global leader in health technology commercialization. Together, we’ll maximize the impact of Ontario’s Life Sciences Innovation Fund (LSIF) and ensure the next generation of Canadian health innovators thrives.

“MaRS, OBIO®, and TIAP recently launched Life Sciences Central to unlock Canada’s full innovation and economic potential by connecting the dots across our ecosystem — from lab space and capital to talent and commercialization support,” said Grace lee Reynolds (MaRS Discovery District), Dr. Maura Campbell (OBIO®) and Parimal Nathwani (TIAP), on behalf of the Life Sciences Central. “As a key partner to OCI, Life Sciences Central brings our collective experience supporting health innovators and scaling life sciences ventures. Together, we’ll maximize the impact of LSIF and ensure the next generation of Canadian health innovators thrives.”